Viewing data from:

MOEXIPRIL HYDROCHLORIDE

ANDA

MOEXIPRIL HYDROCHLORIDE | A076204 | TEVA PHARMACEUTICALS USA INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.9994

per ea

Lowest NADAC/Unit

$0.8877

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00093515001MOEXIPRIL HCL 15 MG TABLET	$0.9994	EA	Generic	—	2026-06-17
00093001701MOEXIPRIL HCL 7.5 MG TABLET	$0.8877	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain2 active DMFs4 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

APOTEX INCMOEXIPRIL HYDROCHLORIDE USP

DMF 191132006

ALIVUS LIFE SCIENCES LTDMOEXIPRIL HYDROCHLORIDE USP

DMF 204262007

PCASInactiveMOEXIPRIL HYDROCHLORIDE

DMF 99421992

ORGAMOL SAInactiveMOEXIPRIL HYDROCHLORIDE

DMF 105201993

ESTEVE QUIMICA SAInactiveMOEXIPRIL HYDROCHLORIDE

DMF 151722000

UCB MANUFACTURING IRELAND LTDInactiveMOEXIPRIL HYDROCHLORIDE

DMF 166702003

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 7.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: May 8, 2003

No patent or exclusivity listings for this strength.

#002 — 15MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: May 8, 2003